CroweS. J.: Underlying Causes of Deafness. Harvey Lectures, 1931–32.
2.
CroweS. J.: Diagnosis and Differential Diagnosis of Deafness. Arch. Otol., 28:663–675 (Nov.), 1938.
3.
GrayA.: The Otosclerotic Problem. J. of Laryng. & Otol., 49:10 (Oct.), 1934.
4.
ShattuckG. C.: Nutritional Deficiency and the Nervous System. J. A. M. A., 111:1729–1734 (Nov. 3), 1938.
5.
SelfridgeGrant: Can Certain Diseases of the Ear, Nose and Throat, Especially Degeneration of the Eighth Nerve, Be Classified as Deficiency Diseases?Laryngoscope (Feb.), 1936.
6.
SelfridgeGrant: Eighth Nerve High Tone Deafness From a Nutritional Standpoint: A Preliminary Report. Annals of Otology, Rhinology and Laryngology, 46:1–93 (March), 1937.
7.
SelfridgeGrant: Chronic Progressive Deafness From a Nutritional Standpoint: A Preliminary Report. Annals of Otology, Rhinology and Laryngology, 46:4–875 (Dec.), 1937.
8.
SelfridgeGrant: Nicotinic Acid and the Eighth Nerve: A Preliminary Report. Annals of Otology, Rhinology and Laryngology (in press).
9.
CovellW. P.NobleL.: The Significance of Myeline Sheath Degeneration for the Cochlear Nerve. Annals of Otology, Rhinology and Laryngology, 46:895–911 (Dec.), 1937.
10.
WilliamsR.SpiesT.: Vitamin B1. First edition. Macmillan Co.
11.
FrenchC.: Vestibular Function in Experimental Beri-beri. Proc. Soc. Exper. Biol. & Med., 30:1158–1160, 1933.
12.
ShattuckG. C.: Landry's Paralysis in Relation to Vitamin B Deficiency. International Clinics, 3:48, 1938. J. B. Lippencott Company.
13.
LewyF. H.: The Pathology of Nerve Deafness. Trans. Am. Otol. Soc., p. 123, 1937.
14.
JolliffeR.GoodhartN.: Effects of B1 Therapy on the Polyneuritis of Alcoholic Addicts. J. A. M. A., 110:6 (Feb. 5), 1938.
15.
MellanbyE.: Experimental Production of Deafness in Young Animals by Diet. J. of Physiol., 94:380–398 (Dec.), 1938.
16.
OnoT.: Experimental Histopathological Studies of the Ears in A, B and C Avitaminosis. Trans. Japanese Path. Soc., 18:172 (Jan.), 1928.
17.
CovellW. P.: Personal Communication (unpublished).
18.
EddyW.DalldorfG.: The Avitaminoses. Williams & Wilkins Co., 1937.
19.
GreenbergD. M.TuftsE. M.: The Nature of Magnesium Tetany. Am. J. of Physiol., 121:2 (Feb.), 1938.
20.
GreenbergD. M.: Experimental Studies on Calcium. Personal Communication (unpublished).
21.
WilliamsR.SpiesT.: Vitamin B1. Macmillan Company, First Edition, page 731.
22.
CowgillG. R.: Human Requirements for Vitamin B1. J. A. M. A., 111:11 (Sept. 10), 1938.
23.
WeissS.: See Jolliffe's and Goodhart's Article (ref. 14).
24.
SteinbergC.: Untoward Effects Resulting From the Use of Large Doses of Vitamin B1. Am. J. Digest Dis., 5:680 (Dec.), 1938.
25.
VilterS.SpiesT.MathewsA.: A Method for the Determination of Nicotinic Acid, Nicotinamide and Possibly Other Pyridine-like Substances in the Human Urine. J. Biol. Chem., 125:1 (Sept.), 1938.
26.
MasonW.CourvilleC.ZiskindE.: Porphyrins in Human Disease. Medicine, 12:413 (Dec.), 1933.
27.
ShattuckG. C.: International Clinics. J. B. Lippencott Co., 3:48:26, 1938.
28.
JansenB. C. P.: Rec. Trav. Chim., 55:1046 (1936).
29.
BargerG.ToddA. R.BergelR.: Ber., 68:2257 (1935).
30.
WestenbrinkH. G. K.GoudsmitJ.: Rec. Trav. Chim., 56:803 (1937).
31.
RitsertK.: Deutsch. med Wochschr., 64:481 (1938).
32.
FischerH.: Neuere Methoden der Isolierung und Nachweis von Porphyrinen. Abderhaldens Handbuch der biologischen Arbeitsmethoden, Abt. I. Teil II, Lief. 211, 1927. u. M. Dezelic: Uber die Einwirkung von Ozon auf Porphyrine. Hoppe-Seylers Z.222:270 (1933).
